During today’s trading session, Intel shares are rising by more than 7% following reports that the company could become a manufacturer of some of Apple’s M-series chips. The market interprets the potential collaboration as an opportunity to strengthen Intel’s position in the semiconductor industry and to rebuild its production capabilities, which is a significant factor in the current geopolitical context.
At this stage, discussions between the companies are still at a very early phase, and there is no certainty that they will result in a finalized agreement. Intel would reportedly produce the lower-end Apple chips starting in 2027, while the more advanced and high-performance chips would continue to be manufactured by the current partner, TSMC. Introducing Intel as an additional supplier allows Apple to diversify its supply chain and aligns with the strategy of promoting domestic production in the United States.
The current rise in Intel’s share price reflects the market’s reaction to the reports about a possible collaboration with Apple and the company’s potential role in producing M-series chips. Following the principle of “buy the rumor, sell the news,” the market reacts to unconfirmed information, while the further development of the situation remains uncertain and could affect the company’s valuation at any time.
Daily Summary: Wall Street and energy markets end the month on a wave of gains.
Silver Sets Fresh Record Highs!
US Open: After a Day Off, Wall Street Opens the Session in the Green
Three Markets to Watch Next Week (28.11.2025)
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
